Navigation Links
Campbell Alliance Business Development Practice Leader to Co-Chair and Keynote at SRI Pharma Licensing Summit
Date:12/5/2007

RALEIGH, N.C., Dec. 5 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Ben Bonifant, Vice President of the firm's Business Development practice, will serve as conference chairperson and deliver the keynote presentation at the Strategic Research Institute's (SRI) Pharma & Biotech Licensing and Deal-Making Summit. The event will be held on December 10-11, 2007, at the San Diego Marriott La Jolla in La Jolla, California.

Mr. Bonifant's keynote address, titled "When to Do the Deal: How to Know the Time Is Right," will be the opening presentation on Monday, December 10, at 9:00 a.m. The session will address the difficulty licensing executives face when trying to identify the point when risk and financial reward are optimally balanced. Making this decision is difficult because the characteristics and risk profiles of each asset vary. In addition, Mr. Bonifant will dissect other common problems facing licensing executives and outline an approach that decision-makers can apply to answer the question, "When should we do the deal?"

"For licensing executives, the question of when to complete a deal can be a difficult one. For example, an out-licensor may wonder if it makes more sense to complete a deal earlier in development, thereby transferring more risk to its partner but reducing its own financial rewards," stated Mr. Bonifant. "On the other hand, the out-licensor may wonder if it's better to wait until a later stage of development, exposing itself to greater risk of failure, but keeping the door open for greater financial returns," Bonifant added.

Mr. Bonifant has been a management consultant for nearly 15 years, helping leaders of global pharmaceutical and biotech organizations and decision makers in large private equity funds. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals, and he is a frequent guest lecturer at some of the nation's premier universities. Mr. Bonifant earned an MBA from the Stanford Graduate School of Business.

For more information on the SRI Pharma & Biotech Licensing and Deal-Making Summit, please visit http://www.almevents.com/conf_page.cfm?instance_id=27&web_id=918&pid=525

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.

About the Business Development Practice at Campbell Alliance

The Business Development practice at Campbell Alliance helps licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing BD strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.

The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech BD who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out- licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives in charting new strategies in corporate development.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
2. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
3. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
4. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
7. Statement from the Alliance for Quality Nursing Home Care
8. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
9. California Alliance Applauds Governors Support of Group Home Reform for Foster Youth
10. Nations Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract
11. National Alliance for Hispanic Health Ramps Up Lobbying for SCHIP Veto Override
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: